Sardenya is a high-quality hyaluronic acid filler certified by the European Directorate for the Quality of Medicines (EDQM). This filler is created by HoPE (Homogeneous Process and Equilibration) Technology, who optimized for maintaining uniform crosslinking of HA. Sardenya has excellent volumizing effect due to high storage modulus, which helps shape the contour of the procedure site.
Benefits of Sardenya:
- endotoxin is less than 0.04 EU / mg
- produced from non-animal ingredients and no skin test is required before the procedure
- HA of Sardenya has a high molecular weight and its high crosslinking rate slows decomposition
- provides natural and long-lasting procedure results
- contains lidocaine for enhancement of patient satisfaction
Sardenya Deep has medium severity of elasticity and used for correction of moderate skin defects.
Scope of Sardenya Deep:
- correction of medium and deep wrinkles and creases
- correction of nasolabial folds
- maximum lip augmentation
- face contour reinforcement
- correction of sagging skin (gravitational ptosis)
- replenishment of tissue deficiency
Aesthetic effect lasts from 12 to 18 months.
Product composition: HA 24 mg/ml, Lidocaine 0.3%
Sardenya Deep
1 syringe × 1.1 ml per pack
Needle: 27G
Manufacturer: RFBio Co.,Ltd., South Korea
The product has contraindications. We are not responsible for any negative effects that you may encounter after administering products by yourself. It is recommended to consult a doctor or medical professional for any procedure.
Cleviel Contour
Dysport 500 units
Revolax Sub-Q Lidocaine
Botulax 200ui
Neuramis Lidocaine
Kabelline
Soonsu Shining Peel
S-DNA
Chaeum Premium 3
Elasty G Plus
Miracle Touch Up – BR
Rejeunesse Sparkle
Re N TOX 100ui
HyalDew Fine without lido
Ammi Diamond
Hyafilia ME:DAM Deep Plus
Hyaron
Dermalax Implant Plus
Allergan 100 units
Dermalax Plus
Etrebelle 200
Neuronox 100ui
Rejuran HB
Snow Flower Bloom
VOM Intense
Rejuran
Recell
DeneB Classic S
Yvoire Volume Plus
Exquiller Sub-Q
High Inj.
Miracle L
Dermaren Lumi Eyes
Curacen Inj. 